(Q39721583)

14 September 2017

1 reference

title

The Prolactin Response in Clinical Psychiatry (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

24 June 2022

0 references

P. H. Gruen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A347199

24 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=347199

24 June 2022

publication date

1 March 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0025712516318156?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

https://api.elsevier.com/content/article/PII:S0025712516318156?httpAccept=text/plain

24 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Medical Clinics of North America

24 June 2022

published in

1 reference

14 September 2017

volume

62

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

409-424

1 reference

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs

14 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

3 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system

3 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Determination of homovanillic acid turnover in man

3 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Behavioral effects of l-Dopa in schizophrenic patients

3 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of clozapine on cerebral catecholaminergic neurone systems

3 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The effects of phenothiazines on endocrine function: II. Effects in men and post-menopausal women

3 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea

3 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.

3 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Identification and terminal distribution of the tubero-hypophyseal monoamine fibre systems in the rat by means of stereotaxic and microspectrofluorimetric techniques

3 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Evidence of an incerto-hypothalamic dopamine neurone system in the rat

3 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures.

3 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

5-Hydroxyindoleacetic acid (5 HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines

3 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Central dopamine turnover in schizophrenic syndromes.

3 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs

3 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons

3 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical Appraisal

3 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat

3 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

3 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Central monoamine metabolism in man. Effect of putative dopamine receptor agonists and antagonists

3 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders

3 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Drug-Induced Extrapyramidal Symptoms and Their Relations to Clinical Efficacy

3 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

3 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Antipsychotic drugs stimulate prolactin release

3 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system

3 April 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

3 April 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dose equivalence of the antipsychotic drugs

3 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Recent developments in the drug treatment of schizophrenia

3 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Experimental neurological syndromes and the new drug therapies in psychiatry

3 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of Haloperidol on Serum and Pituitary Prolactin, LH and FSH, and Hypothalamic PIF and LRF

3 April 2023

38

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats

3 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

3 April 2023

Human Prolactin

44

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Neuropharmacologic control of neuroendocrine function in man

3 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Further evidence for the existence of tubero-infundibular dopamine neurons.

3 April 2023

46

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Morphological and Functional Aspects of Central Monoamine Neurons

3 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

3 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Drug therapy. Benzodiazepines (first of two parts).

3 April 2023

50

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

3 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system

3 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia

3 April 2023

59

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Choice of Antipsychotic Drugs

3 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A radioimmunoassay for human prolactin

3 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine Receptors in the Brain

3 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

3 April 2023

63

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?

3 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on Prolactin Release1

3 April 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Stimulation of human prolactin secretion by sulpiride

3 April 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Chlorpromazine Metabolism VIII: Blood Levels of Chlorpromazine and Its Sulfoxide in Schizophrenic Patients

3 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Localization of Dopamine and Norepinephrine in the Medial Basal Hypothalamus of the Rat

3 April 2023

70

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Stimulation of tubero-infundibular dopamine neurones and gonadotrophin secretion

3 April 2023

71

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Pharmacotherapy of schizophrenia

3 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients

3 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Amine metabolism in the human brain: Further evaluation of the probenecid test

3 April 2023

77

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Mechanism of the Effects of Hypothalamic Deafferentation on Prolactin Secretion in the Rat1

3 April 2023

78

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

3 April 2023

79

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Evidence for a direct effect of thyrotropin-releasing hormone (TRH) on prolactin release in humans

3 April 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Mesencephalic dopamine neurons projecting to neocortex

3 April 2023

84

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats

3 April 2023

85

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of Central Acting Drugs on Serum and Pituitary Prolactin Levels in Rats

3 April 2023

86

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients

3 April 2023

89

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of sulpiride on serum prolactin levels in humans

3 April 2023

90

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine and the pharmacology of schizophrenia: the state of the evidence

3 April 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Clozapine increases rat serum prolactin levels

3 April 2023

94

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

3 April 2023

95

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Serum prolactin levels in unmedicated schizophrenic patients

3 April 2023

96

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Dopamine antagonism by thioridazine in schizophrenia

3 April 2023

97

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography

3 April 2023

98

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A dopamine-sensitive adenylate cyclase in anterior limbic cortex and mesolimbic region of primate brain

3 April 2023

99

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain

3 April 2023

100

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Tuberoinfundibular neurons: dopaminergic and norepinephrinergic sensitivity

3 April 2023

101

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Human Prolactin and Growth Hormone Release during Surgery and other Conditions of Stress1

3 April 2023

102

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs

3 April 2023

103

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of Blockade of Dopaminergic Receptors on Prolactin and LH Release: Median Eminence and Pituitary Sites of Action

3 April 2023

105

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of drugs used in psychoses on cerebral dopamine metabolism

3 April 2023

106

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Post-mortem fluorescence histochemistry of monoamine neuron systems in the human brain: a new approach in the search for a neuropathology of schizophrenia

3 April 2023

107

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Norepinephrine and dopamine content of hypothalamic nuclei of the rat.

3 April 2023

109

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Acid Metabolites from Monoamines in Cerebrospinal Fluid of Chronic Schizophrenics

3 April 2023

110

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients

3 April 2023

111

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Thioridazine Stimulates Prolactin Secretion in Man

3 April 2023

116

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Human Prolactin: 24-Hour Pattern with Increased Release during Sleep

3 April 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The nocturnal rise of human prolactin is dependent on sleep

3 April 2023

118

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Hypothalamic regulatory hormones

3 April 2023

119

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

3 April 2023

122

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The possible role of metabolites in therapeutic response to chlorpromazine treatment

3 April 2023

123

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A rating scale for extrapyramidal side effects

3 April 2023

124

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A Homologous Radioimmunoassay for Human Prolactin1

3 April 2023

125

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Catecholamines in the brain as mediators of amphetamine psychosis

3 April 2023

127

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines

3 April 2023

128

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Drugs, neurotransmitters, and schizophrenia

3 April 2023

129

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

3 April 2023

130

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

An anatomy of schizophrenia?

3 April 2023

133

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

A pilot study of pimozide in chronic schizophrenic patients

3 April 2023

134

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Hypothalamic Control of the Anterior Pituitary

3 April 2023

135

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel

3 April 2023

136

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

3 April 2023

Q64866629

140

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Changes in the Catecholamine Content of the Rat Hypothalamus Following Deafferentation

3 April 2023

141

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory turbercle of the rat

3 April 2023

142

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

The Effect of Long Term Phenothiazine Therapy on Plasma Prolactin

3 April 2023

143

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

2 Neuroendocrine effects of psychotropic drugs

3 April 2023

144

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31815-6

3 April 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=347199

24 June 2022

1 reference